Protocol Page


	Study ID (Protocol Number)
	CV181-058


	STUDY LOCATIONS*
	Akron Children's Hospital Akron, OH 44308 Recruiting	Alzohaili Medical Consultants Dearborn, MI 48124 Recruiting
	Alianza Research, Inc. Chicago, IL 60611 Recruiting	Arnold Palmer Hosp Ped Endocrinology Specialty Practice Orlando, FL 32806 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
	STUDY OVERVIEW
	The purpose of this study is to evaluate the efficacy, safety, tolerability, of Saxagliptin in pediatric patients with type 2 diabetes.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.